These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
|
(Address of Principal Executive Offices, zip code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
|
☒
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐ |
Smaller Reporting Company
|
|
|
Emerging growth company
|
|
| F-1 | |
| F-1 | |
| F-1 | |
| F-3 | |
| F-4 | |
| F-5 | |
| F-7 | |
| F-9 | |
| 3 | |
| 18 | |
| 19 | |
| 20 | |
| 20 | |
| 20 | |
| 21 | |
| 21 | |
| 22 | |
| 22 | |
| 22 | |
| 22 |
|
P
ART I. FINANCIAL INFORMATION
|
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted cash
|
|
|
||||||
|
Marketable securities
|
|
|
||||||
|
Trade receivables, net of allowances of
$
|
|
|
||||||
|
Inventories, net
|
|
|
||||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total
current assets
|
|
|
||||||
|
LONG-TERM ASSETS:
|
||||||||
|
Marketable securities
|
|
|
||||||
|
Property, plant and equipment, net
|
|
|
||||||
|
Operating lease right-of-use assets, net
|
|
|
||||||
|
Intangible assets, net
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Loan receivables, net
|
|
|
||||||
|
Other long-term assets
|
|
|
||||||
|
Total
long-term assets
|
|
|
||||||
|
Total
assets
|
$
|
|
$
|
|
||||
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
$
|
|
$
|
|
||||
|
Employees and payroll accruals
|
|
|
||||||
|
Warranty obligations
|
|
|
||||||
|
Deferred revenues and customers advances
|
|
|
||||||
|
Accrued expenses and other current liabilities
|
|
|
||||||
|
Convertible senior notes, net
|
|
|
||||||
|
Total
current liabilities
|
|
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Convertible senior notes, net
|
|
|
||||||
|
Warranty obligations
|
|
|
||||||
|
Deferred revenues
|
|
|
||||||
|
Finance lease liabilities
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Other long-term liabilities
|
|
|
||||||
|
Total
long-term liabilities
|
|
|
||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
|
||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
|
Common stock of $
of September 30, 2025 and
shares as of September 30, 2025 and
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Treasury stock, at cost;
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total
stockholders’ equity
|
|
|
||||||
|
Total
liabilities and stockholders’ equity
|
$
|
|
$
|
|
|
Three Months Ended
September 30, |
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Cost of revenues
|
|
|
|
|
||||||||||||
|
Gross profit (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
|
|
|
|
||||||||||||
|
Sales and marketing
|
|
|
|
|
||||||||||||
|
General and administrative
|
|
|
|
|
||||||||||||
|
Other operating expense (income), net
|
(
|
)
|
|
|
|
|||||||||||
|
Total
operating expenses
|
|
|
|
|
||||||||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Financial income (expense), net
|
|
|
|
(
|
)
|
|||||||||||
|
Other income (expense), net
|
(
|
) |
(
|
)
|
(
|
) |
|
|||||||||
|
Loss before income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net loss from equity method investments
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Net basic and diluted loss per share of common stock
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Weighted average number of shares used in computing net basic and diluted loss per share of common stock
|
|
|
|
|
||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other comprehensive income (loss), net of tax:
|
||||||||||||||||
|
Available-for-sale marketable securities
|
|
|
|
|
||||||||||||
|
Cash flow hedges
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Foreign currency translation adjustments
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Total other comprehensive income (loss), net of tax:
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Comprehensive loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Common stock
|
Additional paid in
Capital
|
Treasury stock
|
Accumulated
other comprehensive
loss
|
Accumulated deficit
|
Total
|
|||||||||||||||||||||||
|
Number
|
Amount
|
|||||||||||||||||||||||||||
|
Balance as of January 1, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive gain adjustments
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of March 31, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
*
|
|
|
|
*
|
|||||||||||||||||||||
|
Issuance of common stock under employee stock purchase plan (
|
|
*
|
(
|
)
|
|
|
|
|
||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive gain adjustments
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive loss adjustments
|
-
|
-
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of September 30, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Common stock
|
Additional paid in
Capital
|
Treasury stock
|
Accumulated
other comprehensive
loss
|
Retained earnings (Accumulated deficit)
|
Total
|
|||||||||||||||||||||||
|
Number
|
Amount
|
|||||||||||||||||||||||||||
|
Balance as of January 1, 2024
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Repurchase of common stock
|
(
|
)
|
*
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||
|
Other comprehensive loss adjustments
|
-
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of March 31, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Issuance of common stock under employee stock purchase plan
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Repurchase of common stock
|
(
|
)
|
*
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||
|
Capped call transactions related to Notes 2029
|
-
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||
|
Other comprehensive loss adjustments
|
-
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Capped call transactions related to Notes 2029
|
-
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||
|
Other comprehensive gain adjustments
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of September 30, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Nine Months Ended
September 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
Loss on impairment and disposal of property, plant and equipment
|
|
|
||||||
|
Provision to write down inventories to net realizable value
|
|
|
||||||
|
Impairment of asset held-for-sale
|
|
|
||||||
|
Impairment of goodwill and intangible assets
|
|
|
||||||
|
Impairment of privately-held companies
|
|
|
||||||
|
Stock-based compensation expenses
|
|
|
||||||
|
Loss from business disposition
|
|
|
||||||
|
Deferred income taxes, net
|
(
|
)
|
|
|||||
|
Gain from repurchasing of convertible notes
|
|
(
|
)
|
|||||
|
Loss from exchange rate fluctuations
|
|
|
||||||
|
Loss (gain) from sale of property, plant and equipment
|
(
|
)
|
|
|||||
|
Other items
|
(
|
)
|
|
|||||
|
Changes in assets and liabilities:
|
||||||||
|
Trade receivables, net
|
(
|
)
|
|
|||||
|
Inventories, net
|
|
|
||||||
|
Prepaid expenses and other assets
|
|
|
||||||
|
Operating lease right-of-use assets, net
|
|
|
||||||
|
Trade payables
|
|
(
|
)
|
|||||
|
Warranty obligations
|
(
|
)
|
(
|
)
|
||||
|
Deferred revenues and customers advances
|
(
|
)
|
|
|||||
|
Operating lease liabilities
|
(
|
)
|
(
|
)
|
||||
|
Accrued expenses and other liabilities
|
|
|
||||||
|
Net cash provided by (used in) operating activities
|
|
(
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Investment in available-for-sale marketable securities
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from maturities of available-for-sale marketable securities
|
|
|
||||||
|
Proceeds from sales of available-for-sale marketable securities
|
|
|
||||||
|
Purchase of property, plant and equipment
|
(
|
)
|
(
|
)
|
||||
|
Business combinations, net of cash acquired
|
|
(
|
)
|
|||||
|
Proceeds from sale of investment in privately-held company
|
|
|
||||||
|
Business dispositions, net of cash sold
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from sale of property, plant and equipment
|
|
|
||||||
|
Repayment related to governmental grant
|
(
|
)
|
|
|||||
|
Purchase of intangible assets
|
|
(
|
)
|
|||||
|
Disbursements for loans receivables
|
|
(
|
)
|
|||||
|
Investment in privately-held companies
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from loan receivables
|
|
|
||||||
|
Other investing activities
|
|
(
|
)
|
|||||
|
Net cash provided by investing activities
|
$
|
|
$
|
|
||||
|
Nine Months Ended
September 30, |
||||||||
|
2025
|
2024
|
|||||||
|
Cash flows from financing activities:
|
||||||||
|
Repurchase of common stock
|
$
|
|
$
|
(
|
)
|
|||
|
Proceeds from issuance of Notes 2029, net of issuance costs
|
|
|
||||||
|
Capped call transactions related to Notes 2029
|
|
(
|
)
|
|||||
|
Payment for settlement of convertible notes
|
(
|
)
|
|
|||||
|
Repurchase of convertible debt
|
(
|
)
|
(
|
)
|
||||
|
Other financing activities
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
||||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
(
|
)
|
|||||
|
Increase (decrease) in cash, cash equivalents and restricted cash
|
|
(
|
)
|
|||||
|
Cash, cash equivalents and restricted cash, beginning of period
|
|
|
||||||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
|
$
|
|
||||
|
Nine Months Ended
September 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted cash
|
|
|
||||||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
| a. |
SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell intelligent inverter solutions designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughout each and every module through constant tracking of maximum power points individually per module, (ii) inverters which invert direct current (“DC”) from the PV modules to alternating current (“AC”), including the Company’s future ready Energy Hub inverter which supports, among other things, connection to a DC-coupled battery for full or partial home backup capabilities, and optional connection to the Company's smart EV charger, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners to monitor and manage the solar PV system, (iv) batteries for PV applications that are used to increase energy independence and maximize self-consumption for PV system's owners including a battery and (v) additional smart energy management solutions.
|
| b. |
Basis of Presentation:
|
| c. |
Trade receivables:
|
|
Balance as of January 1, 2025
|
$
|
|
||
|
Increase in provision for expected credit losses
|
|
|||
|
Recoveries collected
|
(
|
)
|
||
|
Amounts written off charged against the allowance
|
(
|
)
|
||
|
Foreign currency translation
|
|
|||
|
Balance as of September 30, 2025
|
$
|
|
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 9
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
| d. |
Use of estimates:
|
| e. |
Concentrations of supply risks:
|
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 10
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
| g. |
New accounting standards updates:
|
| h. |
Revision to previously issued financial statements
:
|
|
Three Months Ended September 30, 2024
|
Nine Months Ended September 30, 2024
|
|||||||||||||||||||||||
|
As reported
|
Adjustment
|
As revised
|
As reported
|
Adjustment
|
As revised
|
|||||||||||||||||||
|
Revenues
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||
|
Gross loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Operating loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
|
EPS
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Nine Months Ended September 30, 2024
|
||||||||||||
|
As reported
|
Adjustment
|
As revised
|
||||||||||
|
Cash flows provided by operating activities:
|
||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$ |
(
|
)
|
|||
|
Net cash used in operating activities
|
$
|
(
|
)
|
$
|
(
|
)
|
$ |
(
|
)
|
|||
|
Net cash provided by investing activities
|
$
|
|
$
|
|
$ |
|
||||||
|
As of September 30, 2024
|
||||||||||||
|
As reported
|
Adjustment
|
As revised
|
||||||||||
|
Accumulated deficit
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Total stockholders’ equity
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 11
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Amortized cost
|
Gross unrealized gains
|
Gross unrealized losses
|
Fair value
|
|||||||||||||
|
Matures within one year:
|
||||||||||||||||
|
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
U.S. Treasury securities
|
|
|
(
|
)
|
|
|||||||||||
|
U.S. Government agency securities
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Amortized cost
|
Gross unrealized gains
|
Gross unrealized losses
|
Fair value
|
|||||||||||||
|
Matures within one year:
|
||||||||||||||||
|
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
U.S. Treasury securities
|
|
|
(
|
)
|
|
|||||||||||
|
U.S. Government agency securities
|
|
|
|
|
||||||||||||
|
|
|
(
|
)
|
|
||||||||||||
|
Matures after one year:
|
||||||||||||||||
|
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
|
U.S. Government agency securities
|
|
|
|
|
||||||||||||
|
|
|
(
|
)
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 12
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
Raw materials
|
$
|
|
$
|
|
||||
|
Work in process
|
|
|
||||||
|
Finished goods
|
|
|
||||||
|
Total inventories, net
|
$
|
|
$
|
|
||||
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
Vendor non-trade receivables
1
|
$
|
|
$
|
|
||||
|
Government authorities
2
|
|
|
||||||
|
Prepayments
|
|
|
||||||
|
Asset held for sale
|
|
|
||||||
|
Other
|
|
|
||||||
|
Total prepaid expenses and other current assets
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 13
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
Cloud computing arrangements
|
$
|
|
$
|
|
||||
|
Investments in privately held companies
|
|
|
||||||
|
Severance pay fund
|
|
|
||||||
|
Prepaid expenses and other
|
|
|
||||||
|
Total other long term assets
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 14
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Balance sheet location
|
September 30,
2025
|
December 31,
2024 |
|||||||
|
Derivative assets of options and forward contracts:
|
|||||||||
|
Designated cash flow hedges
|
Prepaid expenses and other current assets
|
$
|
|
$
|
|
||||
|
Non-designated hedges
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total derivative assets
|
$
|
|
$
|
|
|||||
|
Derivative liabilities of options and forward contracts:
|
|||||||||
|
Non-designated hedges
|
Accrued expenses and other current liabilities
|
$
|
(
|
)
|
$
|
|
|||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||||||
|
Affected line item
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Foreign exchange contracts
|
|||||||||||||||||
|
Non Designated Hedging Instruments
|
Condensed Consolidated Statements of Loss - Financial income (expense), net
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Designated Hedging Instruments
|
Condensed Consolidated Statements of Comprehensive Loss - Cash flow hedges
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 15
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Fair value measurements as of
|
||||||||||
|
Description
|
Fair Value
Hierarchy
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
Assets:
|
||||||||||
|
Cash and cash equivalents:
|
||||||||||
|
Cash
|
Level 1
|
$
|
|
$
|
|
|||||
|
Money market mutual funds
|
Level 1
|
$
|
|
$
|
|
|||||
|
Deposits
|
Level 1
|
$
|
|
$
|
|
|||||
|
Restricted cash
|
Level 1
|
$
|
|
$
|
|
|||||
|
Derivative instruments
|
Level 2
|
$
|
|
$
|
|
|||||
|
Short-term marketable securities:
|
||||||||||
|
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
|
U.S. Treasury securities
|
Level 2
|
$
|
|
$
|
|
|||||
|
U.S. Government agency securities
|
Level 2
|
$
|
|
$
|
|
|||||
|
Long-term marketable securities:
|
||||||||||
|
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
|
U.S. Government agency securities
|
Level 2
|
$
|
|
$
|
|
|||||
|
Liabilities:
|
||||||||||
|
Derivative instruments
|
Level 2
|
$
|
(
|
)
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 16
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Balance, at the beginning of the period
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Accruals for warranty during the period
|
|
|
|
|
||||||||||||
|
Changes in estimates
|
|
|
(
|
)
|
|
|||||||||||
|
Settlements
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Balance, at end of the period
|
|
|
|
|
||||||||||||
|
Less current portion
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Long term portion
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 17
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Balance, at the beginning of the period
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Revenue recognized
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Increase in deferred revenues and customer advances
|
|
|
|
|
||||||||||||
|
Balance, at the end of the period
|
|
|
|
|
||||||||||||
|
Less current portion
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Long term portion
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2025
|
$
|
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
Thereafter
|
|
|||
|
Total deferred revenues
|
$
|
|
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
Accrued expenses
|
$
|
|
$
|
|
||||
|
Government authorities
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Accrual for sales incentives
|
|
|
||||||
|
Provision for legal claims
|
|
|
||||||
|
Other
|
|
|
||||||
|
Total accrued expenses and other current liabilities
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 18
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 19
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 20
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
September 30, 2025
|
December 31, 2024
|
|||||||
|
Notes 2025
|
||||||||
|
Principal
|
$
|
|
$
|
|
||||
|
Unamortized issuance costs
|
|
(
|
)
|
|||||
|
Net carrying amount Notes 2025
|
|
|
||||||
|
Notes 2029
|
||||||||
|
Principal
|
|
|
||||||
|
Unamortized issuance costs
|
(
|
)
|
(
|
)
|
||||
|
Net carrying amount Notes 2029
|
|
|
||||||
|
Total notes carrying amount
|
$
|
|
$
|
|
||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Notes 2025
|
||||||||||||||||
|
Debt issuance cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Notes 2029
|
||||||||||||||||
|
Debt issuance cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Contractual interest expense
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
September 30,
2025
|
December 31,
2024
|
|||||||
|
Tax liabilities
|
$
|
|
$
|
|
||||
|
Accrued severance pay
|
|
|
||||||
|
Long term accrued expenses
|
|
|
||||||
|
Other
|
|
|
||||||
|
$
|
|
$
|
|
|||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 21
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
| a. |
Common stock rights:
|
| b. |
Equity Incentive Plans:
|
|
Number of
options
|
Weighted
average
exercise price
|
Weighted
average
remaining
contractual
term in years
|
Aggregate
intrinsic Value
|
|||||||||||||
|
Outstanding as of
December 31, 2024
|
|
$
|
|
|
$
|
|
||||||||||
|
Exercised
|
(
|
)
|
|
-
|
|
|||||||||||
|
Forfeited or expired
|
(
|
)
|
|
-
|
-
|
|||||||||||
|
Outstanding as of
September 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
|
Vested and expected to vest as of
September 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
|
Exercisable as of
September 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 22
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
RSU
|
PSU
|
|||||||||||||||
|
Number of
Shares
Outstanding
|
Weighted average grant date fair value
|
Number of
Shares
Outstanding
|
Weighted average grant date fair value
|
|||||||||||||
|
Unvested as of December 31, 2024
|
|
$
|
|
|
$
|
|
||||||||||
|
Granted
|
|
|
|
|
||||||||||||
|
Vested
|
(
|
)
|
|
|
|
|||||||||||
|
Forfeited
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Unvested as of September 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
| c. |
Employee Stock Purchase Plan (“ESPP”):
|
| d. |
Stock-based compensation expenses:
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Stock-based compensation expenses:
|
||||||||||||||||
|
Cost of revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Research and development
|
|
|
|
|
||||||||||||
|
Sales and marketing
|
|
|
|
|
||||||||||||
|
General and administrative
|
|
|
|
|
||||||||||||
|
Total stock-based compensation expenses
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Stock-based compensation capitalized:
|
||||||||||||||||
|
Inventory
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Other long-term assets
|
|
|
|
|
||||||||||||
|
Total stock-based compensation capitalized
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 23
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
| a. |
Guarantees:
|
| b. |
Contractual purchase obligations:
|
| c. |
Legal claims:
|
Plaintiffs filed a motion for class certification on October 17, 2025. Defendants’ deadline to file an opposition to Plaintiffs’ motion is January 16, 2025.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 24
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 25
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Unrealized gains (losses) on available-for-sale marketable securities
|
||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||
|
Revaluation
|
|
|
|
|
||||||||||||
|
Tax on revaluation
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Other comprehensive income before reclassifications
|
|
|
|
|
||||||||||||
|
Reclassification
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Tax on reclassification
|
|
|
|
|
||||||||||||
|
Gains reclassified from accumulated other comprehensive income (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Net current period other comprehensive income
|
|
|
|
|
||||||||||||
|
Ending balance
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Unrealized gains (losses) on cash flow hedges
|
||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Revaluation
|
|
|
|
(
|
)
|
|||||||||||
|
Tax on revaluation
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
|
Other comprehensive losses (gains) before reclassifications
|
|
|
|
(
|
)
|
|||||||||||
|
Reclassification
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Tax on reclassification
|
|
|
|
|
||||||||||||
|
Gains reclassified from accumulated other comprehensive income (loss)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net current period other comprehensive income (loss)
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Ending balance
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
|
||||||||||||||||
|
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Revaluation
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Ending balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Unrealized gains (losses) on foreign currency translation
|
||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Revaluation
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Ending balance
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Total
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 26
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Details about Accumulated Other
Comprehensive Loss Components
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
Affected Line Item in the
Statement of Loss
|
||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
||||||||||||||
|
Unrealized gains (losses) on available-for-sale marketable securities
|
|||||||||||||||||
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Financial income (expense), net
|
|||||||
|
|
(
|
)
|
|
(
|
)
|
Income taxes
|
|||||||||||
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Total, net of income taxes
|
|||||||
|
Unrealized gains (losses) on cash flow hedges, net
|
|||||||||||||||||
|
|
|
|
|
Cost of revenues
|
|||||||||||||
|
|
|
|
|
Research and development
|
|||||||||||||
|
|
|
|
|
Sales and marketing
|
|||||||||||||
|
|
|
|
|
General and administrative
|
|||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
Total, before income taxes
|
|||||||||
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
Income taxes
|
|||||||||
|
|
|
|
|
Total, net of income taxes
|
|||||||||||||
|
Total reclassifications for the period
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Impairment of asset-held for sale
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Loss from business disposition
|
|
|
|
|
||||||||||||
|
Loss (gain) from sale of property, plant and equipment
|
|
(
|
)
|
(
|
)
|
|
||||||||||
|
Impairment of intangible assets and goodwill
|
|
|
|
|
||||||||||||
|
Impairment and disposal by abandonment of property, plant and equipment
|
|
|
|
|
||||||||||||
|
Other
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Total other operating expense (income), net
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 27
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended September 30, 2025
|
Three Months Ended September 30, 2024
|
|||||||||||||||||||||||
|
Employee termination costs
|
Contract termination and other
|
Total
|
Employee termination costs
|
Contract termination and other
|
Total
|
|||||||||||||||||||
|
Cost of revenues
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||
|
Research and development
|
(
|
)
|
|
(
|
)
|
|
|
|
||||||||||||||||
|
Sales and marketing
|
|
|
|
|
|
|
||||||||||||||||||
|
General and administrative
|
|
|
|
|
|
|
||||||||||||||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Nine Months Ended September 30, 2025
|
Nine Months Ended September 30, 2024
|
|||||||||||||||||||||||
|
Employee termination costs
|
Contract termination and other
|
Total
|
Employee termination costs
|
Contract termination and other
|
Total
|
|||||||||||||||||||
|
Cost of revenues
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Research and development
|
|
|
|
|
|
|
||||||||||||||||||
|
Sales and marketing
|
|
|
|
|
|
|
||||||||||||||||||
|
General and administrative
|
|
|
|
|
|
|
||||||||||||||||||
|
Other operating expenses
|
|
(
|
)
|
(
|
)
|
|
|
|
||||||||||||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 28
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Employee termination costs
|
Contract termination and other
|
|||||||
|
Balance as of December 31, 2024
|
$
|
|
$
|
|
||||
|
Charges
|
|
(
|
)
|
|||||
|
Cash payments
|
(
|
)
|
(
|
)
|
||||
|
Non-cash utilization and other
|
|
(
|
)
|
|||||
|
Balance as of September 30, 2025
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 29
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Basic and diluted EPS:
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Denominator:
|
||||||||||||||||
|
Shares used in computing net loss per share of common stock, basic and diluted
|
|
|
|
|
||||||||||||
|
Loss per share:
|
||||||||||||||||
|
Basic and Diluted
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Stock-based awards
|
|
|
|
|
||||||||||||
|
Notes 2025
|
|
|
|
|
||||||||||||
|
Notes 2029
1
|
|
|
|
|
||||||||||||
|
Total shares excluded
|
|
|
|
|
||||||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 30
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Less:
|
||||||||||||||||
|
Direct costs of goods
|
|
|
|
|
||||||||||||
|
Salaries
1
|
|
|
|
|
||||||||||||
|
Inventory costs
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Shipment and logistics
|
|
|
|
|
||||||||||||
|
Warranty
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
|
|
|
|
||||||||||||
|
Directly related overhead costs
|
|
|
|
|
||||||||||||
|
Other
2
|
|
|
|
|
|
|||||||||||
|
Financial (income) expense, net
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
|
Income taxes
|
|
|
|
|
||||||||||||
|
Net loss from equity method investments
|
|
|
|
|
||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
United States
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Europe
|
|
|
|
|
||||||||||||
|
International markets
|
|
|
|
|
||||||||||||
|
Total revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| • |
future demand for renewable energy including solar energy solutions;
|
| • |
our ability to forecast demand for our products accurately and to match production to such demand as well as our customers' ability to forecast demand based on inventory levels;
|
| • |
changes in tax laws, tax treaties, and regulations or the interpretation of them, including the Inflation Reduction Act and the One Big Beautiful Bill Act
;
|
| • |
changes in the U.S. and global trade environments, including the imposition and/or increase of import tariffs or other restrictive trade measures;
|
| • |
ability to successfully operate our global operations with a reduced work force;
|
| • |
macroeconomic conditions in our domestic and international markets, such as inflation concerns, interest rates and recessionary concerns;
|
| • |
changes, elimination or expiration of government subsidies and economic incentives for on-grid solar energy applications;
|
| • |
the retail price of electricity derived from the utility grid or alternative energy sources;
|
| • |
interest rates and supply of capital in the global financial markets in general and in the solar market specifically;
|
| • |
competition, including introductions of power optimizer, inverter and solar photovoltaic (“PV”) system monitoring products by our competitors;
|
| • |
developments in alternative technologies or improvements in distributed solar energy generation;
|
| • |
historic cyclicality of the solar industry and periodic downturns;
|
| • |
product quality or performance problems in our products;
|
| • |
loss of key executives, and our ability to retain key personnel and attract additional qualified personnel
|
| • |
shortages, delays, price changes, or cessation of operations or production affecting our suppliers of key components;
|
| • |
delays, disruptions, and quality control problems in manufacturing;
|
| • |
our dependence upon a small number of outside contract manufacturers and limited or single source suppliers;
|
| • |
changes to net metering policies or the reduction, elimination or expiration of government subsidies and economic incentives for on-grid solar energy applications;
|
| • |
capacity constraints, delivery schedules, manufacturing yields, and costs of our contract manufacturers and availability of components;
|
| • |
performance of distributors and large installers in selling our products;
|
| • |
consolidation in the solar industry among our customers and distributors;
|
| • |
our ability to effectively manage changes in our organization, expansion into new markets, or discontinuing businesses;
|
| • |
our ability to recognize expected benefits from restructuring plans;
|
| • |
any unauthorized access to, disclosure, or theft of personal information or unauthorized access to our network or other similar cyber incidents;
|
| • |
our ability to implement our new Enterprise Resource Planning ("ERP") system;
|
| • |
the impact of the continued U.S. government shutdown;
|
| • |
our ability to integrate acquired businesses;
|
| • |
disruption to our business operations due to the evolving state of war in Israel and political conditions related to the war and Israeli government's plans to significantly reduce the Israeli Supreme Court's judicial oversight;
|
| • |
our dependence on ocean transportation to timely deliver our products in a cost-effective manner;
|
| • |
fluctuations in global currency exchange rates;
|
| • |
the impact of evolving legal and regulatory requirements, including corporate social responsibility and sustainability, requirements;
|
| • |
existing and future responses to and effects of pandemics, epidemics or other health crises;
|
| • |
federal, state, and local regulations governing the electric utility industry with respect to solar energy;
|
| • |
business practices and regulatory compliance of our raw material suppliers;
|
| • |
our ability to maintain our brand and to protect and defend our intellectual property;
|
| • |
volatility of our stock price;
|
| • |
our customers’ financial stability, creditworthiness, and debt leverage ratio;
|
| • |
our ability to effectively design, launch, market, and sell new generations of our products and services;
|
| • |
our ability to retain, and events affecting, our major customers;
|
| • |
natural disasters, public health events and other disruptions;
|
| • |
impairment of our goodwill or other long-lived and intangible assets;
|
| • |
our liquidity and ability to service our debt;
and
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Inverters shipped (in thousands)
|
85.6
|
57.6
|
259.0
|
192.3
|
||||||||||||
|
Power optimizers shipped (in thousands)
|
2,903.7
|
1,848.7
|
7,898.0
|
4,921.3
|
||||||||||||
|
Megawatts shipped
1
|
1,471.0
|
850.0
|
3,872.0
|
2,668.0
|
||||||||||||
|
Megawatt hours shipped - batteries for PV applications
|
269.0
|
189.0
|
696.0
|
446.0
|
||||||||||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Inverters recognized as revenue (in thousands)
|
92.7
|
54.2
|
250.8
|
181.9
|
||||||||||||
|
Power optimizers recognized as revenue (in thousands)
|
2,946.7
|
1,762.9
|
7,700.5
|
4,831.3
|
||||||||||||
|
Megawatt hours recognized as revenue - batteries for PV applications
|
230.0
|
185.6
|
617.0
|
405.0
|
||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Revenues
|
$
|
340,177
|
$
|
235,435
|
$
|
849,086
|
$
|
705,239
|
||||||||
|
Cost of revenues
|
268,034
|
963,229
|
727,276
|
1,470,189
|
||||||||||||
|
Gross profit (loss)
|
72,143
|
(727,794
|
)
|
121,810
|
(764,950
|
)
|
||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
54,146
|
70,372
|
169,529
|
214,999
|
||||||||||||
|
Sales and marketing
|
26,911
|
37,427
|
87,293
|
116,316
|
||||||||||||
|
General and administrative
|
26,574
|
41,212
|
76,546
|
111,085
|
||||||||||||
|
Other operating expense (income), net
|
(338
|
)
|
233,929
|
41,811
|
237,271
|
|||||||||||
|
Total
operating expenses
|
107,293
|
382,940
|
375,179
|
679,671
|
||||||||||||
|
Operating loss
|
(35,150
|
)
|
(1,110,734
|
)
|
(253,369
|
)
|
(1,444,621
|
)
|
||||||||
|
Financial income (expense), net
|
3,040
|
5,558
|
5,785
|
(2,371
|
)
|
|||||||||||
|
Other income (expense), net
|
(15,011
|
)
|
(3,928
|
)
|
(10,846
|
)
|
14,623
|
|||||||||
|
Loss before income taxes
|
(47,121
|
)
|
(1,109,104
|
)
|
(258,430
|
)
|
(1,432,369
|
)
|
||||||||
|
Income taxes
|
(2,563
|
)
|
(121,108
|
)
|
(13,946
|
)
|
(85,109
|
)
|
||||||||
|
Net loss from equity method investments
|
(376
|
)
|
(577
|
)
|
(951
|
)
|
(1,440
|
)
|
||||||||
|
Net loss
|
$
|
(50,060
|
)
|
$
|
(1,230,789
|
)
|
$
|
(273,327
|
)
|
$
|
(1,518,918
|
)
|
||||
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended September 30, 2025 to 2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Revenues
|
$
|
340,177
|
$
|
235,435
|
$
|
104,742
|
44.5
%
|
$
|
849,086
|
$
|
705,239
|
$
|
143,847
|
20.4
|
%
|
|||||||||||||||||
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Cost of revenues
|
$
|
268,034
|
$
|
963,229
|
$
|
(695,195
|
)
|
(72.2)
%
|
|
$
|
727,276
|
$
|
1,470,189
|
$
|
(742,913
|
)
|
(50.5
|
)
%
|
||||||||||||||
|
Gross profit (loss)
|
$
|
72,143
|
$
|
(727,794
|
)
|
$
|
799,937
|
(109.9
)%
|
|
$
|
121,810
|
$
|
(764,950
|
)
|
$
|
886,760
|
(115.9
|
)%
|
||||||||||||||
| • |
a decrease of $666.6 million related to prior year inventory write-down accruals; and
|
| • |
a decrease , in direct cost of revenues sold, of $8.6 million, associated primarily with the AMPTC recognized and a decrease in shipment costs, which was partially offset by the increase in the volume of revenues.
|
| • |
a decrease of inventory write-down accruals resulting in higher gross margin of approximately 312.3%; and
|
| • |
lower absolute fixed and other production related costs, which were divided this quarter by significantly higher revenue, resulting in higher gross margin of approximately 22.0%.
|
| • |
a decrease of $676.3 million related to prior year inventory write-down accruals;
|
| • |
a decrease in warranty expenses and warranty accruals of $39.8 million associated primarily with a lower cost of materials;
|
| • |
a decrease in direct cost of revenues sold of $9.2 million associated primarily with the AMPTC recognized and a decrease in shipment costs which was partially offset by the increase in revenues; and
|
| • |
a decrease in personnel-related costs of $10.4 million resulting primarily from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics.
|
| • |
a decrease of inventory write-down accruals resulting in higher gross margin of approximately 111.8%; and
|
| • |
lower absolute fixed and other production related costs, which were divided this period by significantly higher revenue, resulting in higher gross margin of approximately 7.0%;
|
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Research and development
|
$
|
54,146
|
$
|
70,372
|
$
|
(16,226
|
)
|
(23.1)
%
|
|
$
|
169,529
|
$
|
214,999
|
$
|
(45,470
|
)
|
(21.1
|
)
%
|
||||||||||||||
| • |
a decrease in personnel-related costs of $12.9 million resulting primarily from our
Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics;
|
| • |
a decrease
in depreciation and amortization of $1.6 million
; and
|
| • |
a decrease in expenses related to consulting and sub-contracting of $1.5 million
.
|
| • |
a decrease in personnel-related costs of $32.6 million resulting primarily from our
Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics;
|
| • |
a decrease in depreciation and amortization of $4.7 million;
|
| • |
a decrease
in material consumption in an amount of $3.7 million; and
|
| • |
a decrease in expenses related to consulting and sub-contracting of $3.1 million.
|
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Sales and marketing
|
$
|
26,911
|
$
|
37,427
|
$
|
(10,516
|
)
|
(28.1)
%
|
|
$
|
87,293
|
$
|
116,316
|
$
|
(29,023
|
)
|
(25.0
|
)
%
|
||||||||||||||
| • |
a decrease
in
personnel-related costs of $7.9 million
resulting primarily from our
Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics; and
|
| • |
a decrease
of
$1.1 million
in marketing expenses.
|
| • |
a decrease
in
personnel-related costs of $22.9 million
resulting primarily from our
Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics; and
|
| • |
a decrease
of
$2.2 million
in marketing expenses.
|
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
General and administrative
|
$
|
26,574
|
$
|
41,212
|
$
|
(14,638
|
)
|
(35.5)
%
|
|
$
|
76,546
|
$
|
111,085
|
$
|
(34,539
|
)
|
(31.1
|
)
%
|
||||||||||||||
| • |
a decrease
of
$11.3 million
in doub
tful debt expenses
; and
|
| • |
a decrease
in personnel-related costs of
$6.0 million
resulting primarily from our
Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics.
|
| • |
a net reversal of doubtful debt in the amount of $16.8 million in the nine months ended September 30, 2025, compared to an expense of $24.3 million, in the nine months ended September 30, 2024, mainly related to the collection of doubtful debt and a lower amount of provisions for doubtful debts; and
|
| • |
a decrease
in personnel-related costs of
$11.7 million
resulting primarily from our
Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics
;
|
| • |
an increase
of
$11.2 million
related to potential legal claims; and
|
| • |
an increase of $8.1 million primarily due to a penalty for postponing the commencement of our campus lease agreement.
|
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Other operating expense (income), net
|
$
|
(338
|
)
|
$
|
233,929
|
$
|
(234,267
|
)
|
(100.1
)%
|
|
$
|
41,811
|
$
|
237,271
|
$
|
(195,460
|
)
|
(82.4
|
)
%
|
|||||||||||||
| • |
a decrease of $206.7 million in losses related to the impairment of property, plant and equipment;
|
| • |
a decrease of $22.5 million in losses related to the impairment of intangible assets; and
|
| • |
a decrease of $2.3 million in losses related to the impairment of goodwill.
|
| • |
a decrease of $206.4 million in losses related to the impairment of property, plant and equipment;
|
| • |
a decrease of $22.5 million in losses related to the impairment of intangible assets;
|
| • |
a gain in the nine months ended September 30, 2025 of $10.1 million from sale of property, plant, and equipment compared to a loss of $1.8 million in the nine months ended September 30, 2024; and
|
| • |
an increase of $4.2 million in income related to lower than expected discontinuation charges;
|
| • |
an increase of $37.1 million related to impairment of held for sale asset; and
|
| • |
an increase of $18.0 million related to the sale of the PV tracker business.
|
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Financial income (expense), net
|
$
|
3,040
|
$
|
5,558
|
$
|
(2,518
|
)
|
(45.3)
%
|
|
$
|
5,785
|
$
|
(2,371
|
)
|
$
|
8,156
|
(344.0
|
)%
|
||||||||||||||
| • |
$0.4 million expenses in the three months ended September 30, 2025
compared to income of
$4.6 million
as a result of fluctuations in foreign exchange rates, primarily between the Euro and the NIS against the U.S. dollar; and
|
| • |
a decrease of $3.4 million in interest income related to our marketable securities investments;
|
| • |
a decrease
of
$3.9 million due to credit loss related to loans receivable; and
|
| • |
an increase
of
$2.2 million mainly due to interest income from loans receivable.
|
| • |
a decrease
of
$16.5 million in credit loss expenses related to loans receivable; and
|
| • |
$8.2 million income in the nine months ended September 30, 2025 compared to expenses of $0.5 million
in the nine months ended September 30, 2024
, as a result of fluctuations in foreign exchange rates, primarily between the Euro and the NIS against the U.S. dollar,
|
| • |
a decrease of $9.8 million in interest income related to our marketable securities investments.
|
| • |
expense of $3.6 million
in the nine months ended September 30, 2025 compared to income of $0.8 million
in the nine months ended September 30, 2024
due to hedging; and
|
| • |
an increase
of $3.9 million in interest expenses primarily related to our Notes 2029.
|
|
Three months ended September 30, 2025 to 2024
|
Nine months ended September 30, 2025 to 2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Other income (expense), net
|
$
|
(15,011
|
)
|
$
|
(3,928
|
)
|
$
|
(11,083
|
)
|
282.2
%
|
|
$
|
(10,846
|
)
|
$
|
14,623
|
$
|
(25,469
|
)
|
(174.2
|
)%
|
|||||||||||
|
• |
a decrease in income of $15.5 million in gain from the repurchase of the 2025 Notes recognized in prior year; |
|
• |
an increase in expenses of $10.1 million as a result of impairment of investment in privately held company. |
|
• |
a decrease in income of $3.0 million in realized gain from marketable securities; |
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Income taxes
|
$
|
(2,563
|
)
|
$
|
(121,108
|
)
|
$
|
118,545
|
(97.9)
%
|
|
$
|
(13,946
|
)
|
$
|
(85,109
|
)
|
$
|
71,163
|
(83.6
|
)
%
|
||||||||||||
|
Three months ended
September 30,
2025
to
2024
|
Nine months ended
September 30,
2025
to
2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Net loss from equity method investments
|
$
|
(376
|
)
|
$
|
(577
|
)
|
$
|
201
|
(34.8)
%
|
|
$
|
(951
|
)
|
$
|
(1,440
|
)
|
$
|
489
|
(34.0
|
)
%
|
||||||||||||
|
Three months ended September 30, 2025 to 2024
|
Nine months ended September 30, 2025 to 2024
|
|||||||||||||||||||||||||||||||
|
2025
|
2024
|
Change
|
2025
|
2024
|
Change
|
|||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
|
Net loss
|
$
|
(50,060
|
)
|
$
|
(1,230,789
|
)
|
$
|
1,180,729
|
(95.9
)
%
|
|
$
|
(273,327
|
)
|
$
|
(1,518,918
|
)
|
$
|
1,245,591
|
(82.0
|
)%
|
||||||||||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
(In thousands)
|
(In thousands)
|
|||||||||||||||
|
Net cash provided by (used in) operating activities |
$
|
25,608
|
$
|
(89,332
|
)
|
$
|
51,632
|
$
|
(351,123
|
)
|
||||||
|
Net cash provided by investing activities
|
235,594
|
100,998
|
371,781
|
344,222
|
||||||||||||
|
Net cash provided by (used in) financing activities |
(342,927
|
)
|
30,811
|
(349,537
|
)
|
(19,873
|
)
|
|||||||||
|
Increase (decrease) in cash and cash equivalents
|
$
|
(81,725
|
)
|
$
|
42,477
|
$
|
73,876
|
$
|
(26,774
|
)
|
||||||
|
Exhibit
No.
|
|
Description
|
|
Incorporation by Reference
|
|
Filed with this report.
|
||||
|
Filed with this report.
|
||||
|
Furnished with this report.
|
||||
|
Furnished with this report.
|
||||
|
101
|
The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, (vi) Notes to Condensed Consolidated Financial Statements, and (vii) part II, Item 5(c)
|
|||
|
104
|
The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended
September 30, 2025
formatted in Inline XBRL
|
Included in Exhibit 101
|
|
/s/ Shuki Nir
|
|
|
Shuki Nir
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
|
/s/ Asaf Alperovitz
|
|
|
Asaf Alperovitz
|
|
|
Chief Financial Officer
(
Principal Financial Officer
)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|